Monitor for any takedown announcements (prospectus supplements) that would signal immediate dilution. The effective shelf creates ongoing overhang; any offering below current market price would pressure the stock. Key catalyst remains the October 30, 2026 PDUFA date for INO-3107.
INO drugs
INO drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 13 $1.16entry
- T+1 · 4mo ago 0.00%α −0.36% · $1.16
- T+5 · 4mo ago −3.45%α −2.66% · $1.12
- T+20 · 3mo ago −36.52%α −39.70% · $0.7364
- T+60 · 6w ago −2.59%α −6.58% · $1.13
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Inovio Pharmaceuticals' universal shelf registration (S-3) filed July 2, 2026 has become effective, allowing the company to raise up to $300M through sales of common stock, preferred stock, debt, or warrants. This formalizes the dilution overhang flagged in the prior S-3 analysis, as the company can now take down offerings at any time. Filing document content was unavailable, analysis based on metadata and cross-filing context only.
Key Facts
- Shelf registration (S-3) declared effective, Inovio can now sell up to $300M in securities
- Follows S-3 filed July 2, 2026; company has a history of frequent capital raises
- Market cap is ~$97M, making potential dilution substantial relative to current equity value
Financial Impact
Up to $300M in potential capital raise, representing ~3x current market cap; dilution risk is material
Risk Factors
- Imminent or gradual equity issuance diluting existing shareholders
- Stock price pressure from overhang even without immediate takedown
- Execution risk on pipeline development with limited cash runway
Market Snapshot
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
20 reports on INO
7 of 13 bullish or bearish reports moved the stock their way by T+5. Best: +46.23% at T+20 after the Jul 2, 2026 report. 8 of 14 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $1.39 Now $1.40 +0.72% settles Nov 24
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $1.40 Now $1.40 −0.01% settles Nov 24
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $1.41 Now $1.40 −0.71% settles Nov 23
- Nov 10, 20266d ago 8-K Bearish 5/10 Entry $1.48 Now $1.40 +5.08% settles Nov 18
- Nov 9, 20267d ago 8-K Bearish 5/10 Entry $1.51 to $1.40 Now $1.40 +7.28% ▲ +7.28% +5.59% vs SPY
- Nov 6, 202610d ago 424B5 Bearish 5/10 Entry $1.51 to $1.40 Now $1.40 +7.28% ▲ +7.28% +5.59% vs SPY
- Nov 5, 202611d ago Press Release Bearish 6/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
- Nov 5, 202611d ago 8-K Bearish 5/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
- Nov 5, 202611d ago 424B5 Bearish 4/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
- Nov 5, 202611d ago Press Release Bearish 4/10 Entry $1.22 to $1.43 Now $1.40 −15.23% ▼ −17.70% −15.10% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers